Abstract
With the proven overall benefit of neoadjuvant chemotherapy in patients with locally advanced gastric cancer, there has come a need to discriminate responders from non-responders. In this article, the current role of anatomical and molecular imaging in the prediction of response to neoadjuvant therapy in gastric cancer is outlined and future prospects are discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 1650-1656 |
| Journal | World Journal of Gastroenterology |
| Volume | 20 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 21 Feb 2014 |
Keywords
- Gastric cancer
- Neoadjuvant therapy
- Chemotherapy
- Response
- Imaging